Welcome to LookChem.com Sign In|Join Free
  • or
Hubei Jusheng Technology Co., Ltd.,No Side Effect Azithromycin CAS 83905-01-5 for Sensitive Bacterial Infections//file1.lookchem.com/300w/synthetic/2022-01-26-08/71a9ad25-645d-4ee3-af40-68e94267ec27.png
qq

Communicate with Supplier:

Ms. Linda
Ms. Linda: What can I do for you?

No Side Effect Azithromycin CAS 83905-01-5 for Sensitive Bacterial Infections CAS NO.83905-01-5

Min.Order Quantity:
10 Gram
Purity:
99%
Port:
wuhan port/ shanghai port/ tianjing port
Payment Terms:
T/T,MoneyGram

Add to Inquiry Cart

Product Details

Keywords

  • Azithromycin price
  • Azithromycin supplier
  • Azithromycin factory

Quick Details

  • ProName: No Side Effect Azithromycin CAS 83905-...
  • CasNo: 83905-01-5
  • Molecular Formula: C38H72N2O12
  • Appearance: white power
  • Application: Pharmaceutical raw intermediates
  • DeliveryTime: within 5 days after payment
  • PackAge: as request
  • Port: wuhan port/ shanghai port/ tianjing po...
  • ProductionCapacity: 1000 Metric Ton/Month
  • Purity: 99%
  • Storage: dry and cool place
  • Transportation: EMS, HKEMS, DHL, TNT, UPS, Fedex....
  • LimitNum: 10 Gram

Superiority

1. hubei jusheng technology co., ltd., is a global chemical industry manufacturers and suppliers of pharmaceuticals and intermediates in china.

2. the yearly production capacity is 50000mt, 80% for export.we have a professinal export team. both by air and by sea,we ensure that we meet the customer expectations with promptness.
3. our company facing global high-tech pharmaceutical raw materials, high complex new type intermediates, fine chemicals custom synthesis, scale-up production and rare chemicals trade. corey have well-equipped machine, strong technical force and considerate marketing team service.
4. we also have rich experience advantage in basic research, small scale process development, scale-up, industrial technology development & production and cost control.

Details

quick details:

product name: azithromycin
alias: 9-deoxo-9a-methyl-9a-aza-homoerythromycin a; 11-(4-dimethylamino-3-hydroxy-6-methyl-oxan-2-yl)oxy-2-ethyl-3, 4, 10-tr
cas: 83905-01-5
assay: 99%
grade: pharmaceutical grade & veterinary grade
storage: closed, shading preservation
usage: antibiotics used for a variety of sensitive bacterial infections, such as respiratory infection; skin and soft tissue infection.


specifications:

cas: 83905-01-5
assay: 99%
mf: c38h72n2o12
mw: 748.99
appearance: white crystalline powder
density: 1.18 g/cm3
melting point: 113-115º c
boiling point: 822.1 ° c at 760 mmhg
refractive index: 1.536
flash point: 451 ° c
solubilities: insoluble
stability: stable. incompatible with strong oxidizing agents.


description:

azithromycin (trade names zithromax, azyth, sumamed) is an antibiotic useful for the treatment of bacterial infections. it is an azalide, a subclass of macrolide antibiotic. it is derived from erythromycin, with a methyl-substituted nitrogen atom incorporated into the lactone ring, thus making the lactone ring 15-membered. azithromycin is somewhat more potent against certain bacterial species than erythromycin, but its widespread popularity arises primarily from its slow elimination from the body, which allows many infections to be treated with 3-5 days of once-daily administration, compared to 3-4 times a day for up to two weeks for erythromycin.
azithromycin inhibits the growth of bacteria by interfering with their protein synthesis. it binds to the 50s subunit of the bacterial ribosome, and thus inhibits translation of mrna. this mechanism of action is typical of macrolide antibiotics.
this antibiotic is widely used alone or in combination with other drugs to treat otitis media, pharyngitis, community-acquired respiratory infections (including pneumonia), gastrointestinal infections (such as those caused by eating contaminated food), and gonorrhea.
it is on the world health organization's list of essential medicines, a list of the most important medications needed in a basic health system.


application:

azithromycin is used to treat many different infections, including:
acute bacterial exacerbations of chronic obstructive pulmonary disease due to h. influenzae, m. catarrhalis, or s. pneumoniae
acute bacterial sinusitis due to h. influenzae, m. catarrhalis, or s. pneumoniae
community-acquired pneumonia' due to c. pneumoniae, h. influenzae, m. pneumoniae, or s. pneumoniae
acute otitis media caused by h. influenzae, m. catarrhalis or s. pneumoniae
pharyngitis or tonsillitis caused by s. pyogenes as an alternative to first-line therapy in individuals who cannot use first-line therapy
uncomplicated skin and skin structure infections due to s. aureus, s. pyogenes, or s. agalactiae
urethritis and cervicitis due to c. trachomatis or n. gonorrhoeae
genital ulcer disease (chancroid) in men due to h. ducreyi


Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)